Lucid Diagnostics annual return on equity
2021
2022
2023
2024
2025
Lucid Diagnostics Return on Equity (ROE) Growth & History (LUCD)
Lucid Diagnostics's return on equity was −710.60% for fiscal 2025.
View full Lucid Diagnostics company overviewLucid Diagnostics annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −710.60% | +2245.83 pp |
| 2024 | 2024-12-31 | −2,956.43% | −2448.46 pp |
| 2023 | 2023-12-31 | −507.97% | −363.54 pp |
| 2022 | 2022-12-31 | −144.42% | −8.19 pp |
| 2021 | 2021-12-31 | −136.23% | — |
Lucid Diagnostics quarterly return on equity
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −156.59% | +200.67 pp |
| Q1 2026 | 2026-03-31 | −186.25% | +384213.75 pp |
| Q4 2025 | 2025-12-31 | −88.47% | +108.32 pp |
| Q3 2025 | 2025-09-30 | −61.71% | +49.16 pp |
| Q2 2025 | 2025-06-30 | −357.26% | −278.30 pp |
| Q1 2025 | 2025-03-31 | −384,400.00% | −384178.52 pp |
| Q4 2024 | 2024-12-31 | −196.79% | +8644.02 pp |
| Q3 2024 | 2024-09-30 | −110.87% | +50.34 pp |
| Q2 2024 | 2024-06-30 | −78.97% | −22.03 pp |
| Q1 2024 | 2024-03-31 | −221.48% | −153.71 pp |
| Q4 2023 | 2023-12-31 | −8,840.82% | −8781.79 pp |
| Q3 2023 | 2023-09-30 | −161.21% | −116.21 pp |
| Q2 2023 | 2023-06-30 | −56.94% | −21.59 pp |
| Q1 2023 | 2023-03-31 | −67.76% | −43.52 pp |
| Q4 2022 | 2022-12-31 | −59.03% | +14.85 pp |
| Q3 2022 | 2022-09-30 | −45.00% | — |
| Q2 2022 | 2022-06-30 | −35.35% | — |
| Q1 2022 | 2022-03-31 | −24.24% | — |
| Q4 2021 | 2021-12-31 | −73.88% | — |
Lucid Diagnostics return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Lucid Diagnostics's return on equity decreased from −136.23% to −710.60%, a change of −574.37 percentage points. The latest reported quarter, Q2 2026, shows −156.59%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lucid Diagnostics source filings ↗